PerkinElmer Buys Signature for $90M

Xconomy Boston — 

PerkinElmer (NYSE: PKI), the maker of scientific instruments based in Waltham, MA, said today it has agreed to acquire Spokane, WA-based Signature Genomic Laboratories for about $90 million in cash, according to a regulatory filing. The move will enable PerkinElmer to strengthen its genetic testing services and expand into molecular diagnostics, particularly cancer diagnostics, according to a statement. Signature has about 120 employees.